NASDAQ:BIOC - Biocept News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.01 0.00 (0.00 %)
(As of 02/20/2019 06:00 AM ET)
Previous Close$1.01
Today's Range$0.98 - $1.0249
52-Week Range$0.66 - $12.30
Volume1.19 million shs
Average Volume2.56 million shs
Market Capitalization$2.29 million
P/E RatioN/A
Dividend YieldN/A
Beta3.09

Headlines

Biocept (NASDAQ BIOC) News Headlines

Source:
DateHeadline
What Makes Biocept (BIOC) a New Buy StockWhat Makes Biocept (BIOC) a New Buy Stock
finance.yahoo.com - February 13 at 6:41 PM
Short Interest in Biocept Inc (BIOC) Increases By 101.1%Short Interest in Biocept Inc (BIOC) Increases By 101.1%
www.americanbankingnews.com - February 13 at 1:40 AM
Biocept down 44% after pricing equity offeringBiocept down 44% after pricing equity offering
seekingalpha.com - February 8 at 7:10 PM
Biocept Announces Pricing of $7.5 Million Underwritten Public OfferingBiocept Announces Pricing of $7.5 Million Underwritten Public Offering
finance.yahoo.com - February 8 at 7:10 PM
Biocept up 21% premarket on Agiomix dealBiocept up 21% premarket on Agiomix deal
seekingalpha.com - February 7 at 6:47 PM
Biocept Announces Agreement with Agiomix FZ-LLC for Target Selector Liquid Biopsy KitsBiocept Announces Agreement with Agiomix FZ-LLC for Target Selector Liquid Biopsy Kits
finance.yahoo.com - February 7 at 6:47 PM
Biocept up 5% premarket on cases supporting utility of ctDNA testingBiocept up 5% premarket on cases supporting utility of ctDNA testing
seekingalpha.com - February 5 at 6:35 PM
Biocept, Inc., Pipeline Review, Upcoming Catalysts and MilestonesBiocept, Inc., Pipeline Review, Upcoming Catalysts and Milestones
finance.yahoo.com - January 30 at 7:08 PM
Biocept launches circulating tumor DNA test kit; shares up 14% premarketBiocept launches circulating tumor DNA test kit; shares up 14% premarket
seekingalpha.com - January 28 at 6:25 PM
Biocept Launches Liquid Biopsy Kits Intended to Broaden Use of its Proprietary Technology Platform for High Sensitivity Detection of Circulating Tumor DNABiocept Launches Liquid Biopsy Kits Intended to Broaden Use of its Proprietary Technology Platform for High Sensitivity Detection of Circulating Tumor DNA
finance.yahoo.com - January 28 at 8:11 AM
Should You Worry About Biocept, Inc.’s (NASDAQ:BIOC) CEO Salary Level?Should You Worry About Biocept, Inc.’s (NASDAQ:BIOC) CEO Salary Level?
finance.yahoo.com - January 22 at 6:28 PM
Biocept prices $2.2M registered direct offeringBiocept prices $2.2M registered direct offering
seekingalpha.com - January 18 at 5:50 PM
Biocept Announces Pricing of $2.2 Million Registered Direct OfferingBiocept Announces Pricing of $2.2 Million Registered Direct Offering
finance.yahoo.com - January 18 at 5:50 PM
Todays Research Reports on Trending Tickers: Adamis Pharmaceuticals and BioceptToday's Research Reports on Trending Tickers: Adamis Pharmaceuticals and Biocept
finance.yahoo.com - January 17 at 8:14 AM
Biocept up 26% ahead of equity offeringBiocept up 26% ahead of equity offering
seekingalpha.com - January 16 at 5:58 PM
Biocept readies downsized equity offering; shares down 12% premarketBiocept readies downsized equity offering; shares down 12% premarket
seekingalpha.com - December 19 at 8:16 AM
Todays Research Reports on Trending Tickers: Biogen and BioceptToday's Research Reports on Trending Tickers: Biogen and Biocept
finance.yahoo.com - December 19 at 8:16 AM
BRIEF-Biocept And Prognos Enter Into PartnershipBRIEF-Biocept And Prognos Enter Into Partnership
www.reuters.com - December 18 at 5:39 PM
Biocept and Prognos teams up to apply artificial intelligence for commercialization of biomarker-targeted therapies in oncologyBiocept and Prognos teams up to apply artificial intelligence for commercialization of biomarker-targeted therapies in oncology
seekingalpha.com - December 18 at 5:39 PM
Biocept and Prognos Enter Into Partnership to Apply Artificial Intelligence in Order to Help Pharmaceutical and Life Sciences Companies Optimize Commercialization of Biomarker-Targeted Therapies in OncologyBiocept and Prognos Enter Into Partnership to Apply Artificial Intelligence in Order to Help Pharmaceutical and Life Sciences Companies Optimize Commercialization of Biomarker-Targeted Therapies in Oncology
finance.yahoo.com - December 18 at 8:13 AM
Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch - BenzingaDaily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch - Benzinga
www.benzinga.com - December 14 at 8:14 AM
Biocept files for $10M equity offeringBiocept files for $10M equity offering
seekingalpha.com - November 28 at 8:20 AM
What Kind Of Shareholder Appears On The Biocept Inc’s (NASDAQ:BIOC) Shareholder Register?What Kind Of Shareholder Appears On The Biocept Inc’s (NASDAQ:BIOC) Shareholder Register?
finance.yahoo.com - November 20 at 5:23 PM
Biocepts (BIOC) CEO Michael Nall on Q3 2018 Results - Earnings Call TranscriptBiocept's (BIOC) CEO Michael Nall on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 8:12 AM
Biocept Reports Third Quarter 2018 Financial ResultsBiocept Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 13 at 5:15 PM
Biocept to Release Third Quarter 2018 Financial Results and Host Investor Conference Call on November 13, 2018Biocept to Release Third Quarter 2018 Financial Results and Host Investor Conference Call on November 13, 2018
finance.yahoo.com - November 6 at 8:13 AM
Biocept Announces New Executive Hires to its Sales and Marketing OrganizationBiocept Announces New Executive Hires to its Sales and Marketing Organization
finance.yahoo.com - November 5 at 8:23 AM
Biocept (BIOC) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseBiocept (BIOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
www.zacks.com - November 1 at 6:11 PM
Biocept (BIOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseBiocept (BIOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - November 1 at 6:11 PM
Biocept to Present at the Dawson James Securities Small Cap Growth Conference on October 30Biocept to Present at the Dawson James Securities Small Cap Growth Conference on October 30
finance.yahoo.com - October 23 at 8:12 AM
Biocept Obtains Japanese Patent for its Target Selector Oncogene Mutation Enrichment and Detection PlatformBiocept Obtains Japanese Patent for its Target Selector Oncogene Mutation Enrichment and Detection Platform
finance.yahoo.com - October 18 at 8:19 AM
Form SC 13G BIOCEPT INC Filed by: Lincoln Park Capital Fund, LLCForm SC 13G BIOCEPT INC Filed by: Lincoln Park Capital Fund, LLC
www.streetinsider.com - September 25 at 8:11 AM
Biocept Awarded Patent in Hong Kong for its Target Selector Platform Using Antibodies and a Microchannel to Perform ...Biocept Awarded Patent in Hong Kong for its Target Selector Platform Using Antibodies and a Microchannel to Perform ...
www.prnewswire.com - September 25 at 8:11 AM
Biocept to Present at The MicroCap Conference in New York on October 2Biocept to Present at The MicroCap Conference in New York on October 2
finance.yahoo.com - September 25 at 8:11 AM
Biocept Awarded Patent in Hong Kong for its Target Selector Platform Using Antibodies and a Microchannel to Perform Liquid BiopsyBiocept Awarded Patent in Hong Kong for its Target Selector Platform Using Antibodies and a Microchannel to Perform Liquid Biopsy
finance.yahoo.com - September 24 at 8:12 AM
Biocept (BIOC) Reports $2.5 Million Registered Direct Offering of Common Stock, Warrants Priced at MarketBiocept (BIOC) Reports $2.5 Million Registered Direct Offering of Common Stock, Warrants Priced at Market
www.streetinsider.com - September 22 at 8:15 AM
Biocept prices $2.5M registered direct offering at marketBiocept prices $2.5M registered direct offering at market
seekingalpha.com - September 21 at 4:57 PM
Biocept Announces Pricing of $2.5 Million Registered Direct Offering Priced at MarketBiocept Announces Pricing of $2.5 Million Registered Direct Offering Priced at Market
finance.yahoo.com - September 21 at 8:18 AM
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial OfficerBiocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
finance.yahoo.com - September 10 at 8:12 AM
Biocepts Target Selector Platform Featured in Two Poster Presentations at the IASLC 19th World Conference on Lung CancerBiocept's Target Selector Platform Featured in Two Poster Presentations at the IASLC 19th World Conference on Lung Cancer
finance.yahoo.com - September 6 at 8:18 AM
Highmark Healths VITAL Innovation Program testing benefits of Biocepts liquid biopsy platform for improving outcomes and lowering costs of treatment for patients with non-small cell lung cancerHighmark Health's VITAL Innovation Program testing benefits of Biocept's liquid biopsy platform for improving outcomes and lowering costs of treatment for patients with non-small cell lung cancer
finance.yahoo.com - August 23 at 5:07 PM
Biocepts (BIOC) CEO Michael Nall on Q2 2018 Results - Earnings Call TranscriptBiocept's (BIOC) CEO Michael Nall on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 15 at 8:15 AM
Biocept beats by $0.60, misses on revenueBiocept beats by $0.60, misses on revenue
seekingalpha.com - August 14 at 5:41 PM
Biocept Q2 revenue miss pressures shares, down 4% after hoursBiocept Q2 revenue miss pressures shares, down 4% after hours
seekingalpha.com - August 14 at 5:41 PM
Biocept Reports Second Quarter 2018 Financial ResultsBiocept Reports Second Quarter 2018 Financial Results
finance.yahoo.com - August 14 at 5:41 PM
Biocept raises almost $12M in rights offeringBiocept raises almost $12M in rights offering
seekingalpha.com - August 9 at 6:10 PM
Biocept to Release Second Quarter 2018 Financial Results and Host Investor Conference Call on August 14, 2018Biocept to Release Second Quarter 2018 Financial Results and Host Investor Conference Call on August 14, 2018
finance.yahoo.com - August 9 at 6:10 PM
Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights OfferingBiocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering
finance.yahoo.com - August 9 at 8:18 AM
Biocept Announces Agreement with Managed Care Plan to Study the Benefits of Implementing Liquid Biopsy to ...Biocept Announces Agreement with Managed Care Plan to Study the Benefits of Implementing Liquid Biopsy to ...
www.prnewswire.com - August 7 at 8:13 AM
Biocept inks deal with managed care plan to study effectiveness of target selector testingBiocept inks deal with managed care plan to study effectiveness of target selector testing
seekingalpha.com - August 6 at 5:42 PM
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel